Wednesday 12 February 2020
We Are Paradoxx the Clarednon portfolio hair company has unveiled a new cordless three-in-one hair tool.
Thursday 30 January 2020
Clarendon Portfolio company Fusion Antibodies a clinical research firm has reported a strong revenue performance during the third quarter.
The Clarendon portfolio Neurovalens behind the headset developed to treat neurological health issues has been chosen for a major UK-wide programme.
